Stockscreener 앱 받기
11.05
4.99%
-0.58
시간 외 거래:
11.04
-0.01
-0.09%
전일 마감가:
$11.63
열려 있는:
$11.6
하루 거래량:
108.93K
Relative Volume:
0.50
시가총액:
$287.70M
수익:
$47.26M
순이익/손실:
$-58.48M
주가수익비율:
-4.0852
EPS:
-2.7049
순현금흐름:
$-40.45M
1주 성능:
-4.58%
1개월 성능:
-23.74%
6개월 성능:
+40.76%
1년 성능:
-49.47%
1일 변동 폭
$10.93
$11.63
1주일 범위
$10.76
$11.96
52주 변동 폭
$6.40
$22.45
Cvrx Inc Stock (CVRX) Company Profile
명칭
Cvrx Inc
전화
(763) 416-2850
주소
9201 WEST BROADWAY AVENUE, MINNEAPOLIS
CVRX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CVRX
Cvrx Inc
|
11.05 | 287.70M | 47.26M | -58.48M | -40.45M | -2.7049 |
|
ABT
Abbott Laboratories
|
129.89 | 225.27B | 41.95B | 13.40B | 6.35B | 7.65 |
|
BSX
Boston Scientific Corp
|
95.37 | 140.74B | 16.75B | 1.85B | 2.37B | 1.25 |
|
SYK
Stryker Corp
|
363.66 | 138.77B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
92.33 | 118.39B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
67.95 | 39.95B | 5.72B | 4.17B | 259.90M | 6.97 |
Cvrx Inc Stock (CVRX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-01-14 | 업그레이드 | William Blair | Mkt Perform → Outperform |
| 2024-09-10 | 개시 | Cantor Fitzgerald | Overweight |
| 2024-07-11 | 재확인 | Lake Street | Buy |
| 2024-05-01 | 재개 | Craig Hallum | Buy |
| 2024-05-01 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2024-05-01 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2023-01-31 | 개시 | Lake Street | Buy |
| 2022-07-18 | 개시 | Craig Hallum | Buy |
| 2021-07-26 | 개시 | Canaccord Genuity | Buy |
| 2021-07-26 | 개시 | Piper Sandler | Overweight |
| 2021-07-26 | 개시 | William Blair | Outperform |
모두보기
Cvrx Inc 주식(CVRX)의 최신 뉴스
(CVRX) Trading Report - Stock Traders Daily
With A 29% Price Drop For CVRx, Inc. (NASDAQ:CVRX) You'll Still Get What You Pay For - Simply Wall St
Power Shift 25: Medtech firm's new CEO looks to 'build a world-class team' - The Business Journals
CVRx, Inc. (NASDAQ:CVRX) Given Consensus Rating of “Moderate Buy” by Brokerages - Defense World
Analyzing Co-Diagnostics (NASDAQ:CODX) and CVRx (NASDAQ:CVRX) - Defense World
CVRx, Inc. (NASDAQ:CVRX) Short Interest Down 9.8% in January - Defense World
CVRx, Inc. SEC 10-K Report - TradingView
CVRx's SWOT analysis: barostim maker's stock faces reimbursement hurdles - MSN
CVRx's SWOT analysis: barostim maker's stock faces reimbursement hurdles By Investing.com - Investing.com UK
(CVRX) Long Term Investment Analysis - Stock Traders Daily
CVRx announces new real-world evidence demonstrating significant reductions in healthcare utilization with Barostim - GlobeNewswire
Cvrx, Inc. Announces New Real-World Evidence Demonstrating Significant Reductions in Healthcare Utility with Barostim - Marketscreener.com
CVRx, Inc. Presents New Real-World Evidence Demonstrating Significant Reductions in Hospital Visits After Barostim Implantation at THT Conference 2025 - Nasdaq
Institutional owners may take dramatic actions as CVRx, Inc.'s (NASDAQ:CVRX) recent 10% drop adds to one-year losses - Simply Wall St
CVRx (CVRX) Forms 'Hammer Chart Pattern': Time for Bottom Fishing? - MSN
Cantor Fitzgerald Has Negative View of CVRx FY2025 Earnings - MarketBeat
William Blair Weighs in on CVRx's Q2 Earnings (NASDAQ:CVRX) - MarketBeat
Piper Sandler Forecasts Strong Price Appreciation for CVRx (NASDAQ:CVRX) Stock - MarketBeat
CVRx (NASDAQ:CVRX) Price Target Raised to $23.00 at Canaccord Genuity Group - MarketBeat
Wall Street Analysts Predict a 25.76% Upside in CVRx (CVRX): Here's What You Should Know - MSN
William Blair Weighs in on CVRx’s Q2 Earnings (NASDAQ:CVRX) - Defense World
FY2025 EPS Estimates for CVRx Cut by Cantor Fitzgerald - Defense World
CVRx (NASDAQ:CVRX) Issues Quarterly Earnings Results - MarketBeat
CVRX STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into BRONSTEIN, GEWIRTZ & GROSSMAN, LLC and Encourages Investors to Contact the Firm Today! - ACCESS Newswire
Skechers Posts Downbeat Results, Joins e.l.f. Beauty, LiveRamp And Other Big Stocks Moving Lower In Friday's Pre-Market Session - Benzinga
FY2025 EPS Estimates for CVRx Decreased by Cantor Fitzgerald - Armenian Reporter
Calamos Advisors LLC Makes New Investment in CVRx, Inc. (NASDAQ:CVRX) - ETF Daily News
Canaccord Genuity Group Boosts CVRx (NASDAQ:CVRX) Price Target to $23.00 - Defense World
CVRx targets $63M-$65M revenue in 2025 with strengthened sales strategy - MSN
Piper Sandler Raises CVRx (NASDAQ:CVRX) Price Target to $20.00 - Defense World
CVRx Inc [CVRX] Shares Fall -7.20 % on Wednesday - Knox Daily
Should You Invest in CVRx Inc (CVRX) Now? - The News Heater
CVRx’s Earnings Call: Growth Amid Challenges - TipRanks
What 4 Analyst Ratings Have To Say About CVRx - Benzinga
CVRx stock dips on Q4 EPS miss - Mass Device
CVRx (CVRX) Reports Q4 Loss, Tops Revenue Estimates - MSN
Objective long/short (CVRX) Report - Stock Traders Daily
CVRx Announces Strong Revenue Growth in 2024 - TipRanks
CVRx, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2024 - Marketscreener.com
Earnings call transcript: CVRx Q4 2024 shows revenue growth, stock dips - MSN
CVRx Inc reports results for the quarter ended December 31Earnings Summary - TradingView
CVRx Reports Fourth Quarter and Full Year 2024 Financial and Operating Results - GlobeNewswire
CVRx: Q4 Earnings Snapshot -February 04, 2025 at 04:50 pm EST - Marketscreener.com
CVRx: Q4 Earnings Snapshot - Leader-Telegram
Earnings Flash (CVRX) CVRX INC. Reports Q4 Revenue $15.3M, vs. FactSet Est of $15.1M - Marketscreener.com
CVRx Earnings Showcase: Heart Failure Treatment Propels 41% Revenue Explosion in Core Market - StockTitan
CVRx, Inc. (NASDAQ:CVRX) Given Average Recommendation of "Moderate Buy" by Analysts - MarketBeat
CVRx Inc (CVRX) Q4 2024 Earnings Report Preview: What To Expect - Yahoo Finance
Cvrx Inc (CVRX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
3.40%
0.89%
자본화:
|
볼륨(24시간):